{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Oklahoma City",
      "state": "OK",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "77847",
      "recalling_firm": "PD-Rx Pharmaceuticals, Inc.",
      "address_1": "727 N Ann Arbor Ave",
      "address_2": "N/A",
      "postal_code": "73127-5822",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "E-Mail",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-1057-2017",
      "product_description": "Famotidine USP 20 mg, 30 tablets bottle, Rx, PKG By; PD Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 --- NDC 55289-765-30",
      "product_quantity": "100 bottles",
      "reason_for_recall": "Failed Tablet/Capsule Specification: out of specification for tablet weight.",
      "recall_initiation_date": "20170728",
      "center_classification_date": "20170803",
      "termination_date": "20171206",
      "report_date": "20170809",
      "code_info": "Lot: A17F55 Exp. 06/30/2018"
    }
  ]
}